HIGHFDA DRUG
AstraZeneca Recalls Fasenra Injection Due to Sterility Concerns
AstraZeneca recalled 916 pre-filled syringes of Fasenra on October 8, 2025. The recall follows a lack of assurance of sterility, posing serious health risks. Consumers and healthcare providers must stop using the product immediately.
FASENRA
Lack of